Jiangsu Nanfang Medical Co., Ltd.

Shanghai Stock Exchange 603880.SS

Jiangsu Nanfang Medical Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 2.04

Jiangsu Nanfang Medical Co., Ltd. Price to Sales Ratio (P/S) is 2.04 on January 14, 2025, a -15.16% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Jiangsu Nanfang Medical Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 2.67 on December 16, 2024, which is 30.64% above the current Price to Sales Ratio (P/S).
Jiangsu Nanfang Medical Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 1.49 on July 18, 2024, which is -27.15% below the current Price to Sales Ratio (P/S).
Jiangsu Nanfang Medical Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.90.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 603880.SS

Jiangsu Nanfang Medical Co., Ltd.

CEO	Mr. Ping Li
IPO Date	Aug. 7, 2017
Location	China
Headquarters	1 Guoxiang Road
Employees	858
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal products, medical proof fabrics, adhesive tapes, bandages, sports protection products, first-aid kits, and care products in China and internationally. It offers medical adhesive tapes, medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesive plasters, and masks, as well as customized products. The company was founded in 1990 and is based in Changzhou, China.

Key trends

Past 5 years